Status:
COMPLETED
Follow-up Study of Safety of Enteric-coated Mycophenolate Sodium in Patients Who Successfully Completed Study CERL080A302
Lead Sponsor:
Novartis
Conditions:
Renal Transplant
Eligibility:
All Genders
18-75 years
Phase:
PHASE3
Brief Summary
Aim of study is to collect long term safety data on enteric-coated mycophenolate sodium 720 mg bid in combination with cyclosporine with/without steroids in regard to adverse events, serious adverse e...
Eligibility Criteria
Inclusion
- First cadaveric, living unrelated or living related donor kidney transplant recipients who completed study CERL080A302
Exclusion
- Other protocol-defined inclusion/exclusion criteria may apply.
Key Trial Info
Start Date :
February 1 2000
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2003
Estimated Enrollment :
264 Patients enrolled
Trial Details
Trial ID
NCT00149864
Start Date
February 1 2000
End Date
December 1 2003
Last Update
February 2 2011
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.